Judges Scientific (GB:JDG) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Judges Scientific has faced challenging trading conditions in the first half of 2024, with improvements anticipated in the second half. Despite a 4.2% increase in organic order intake year-to-date, the company now expects adjusted earnings per share to be between 270p and 300p, lower than previously forecasted. The board remains confident in the long-term growth prospects of the business.
For further insights into GB:JDG stock, check out TipRanks’ Stock Analysis page.
